HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹762 Cr | ₹815 Cr | ₹748 Cr | ₹674 Cr | ₹609 Cr |
What is the latest Total Debt ratio of HIKAL ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹762 Cr |
| Mar2024 | ₹815 Cr |
| Mar2023 | ₹748 Cr |
| Mar2022 | ₹674 Cr |
| Mar2021 | ₹609 Cr |
How is Total Debt of HIKAL Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹762 Cr | -6.47 | |
| Mar2024 | ₹815 Cr | 8.94 | |
| Mar2023 | ₹748 Cr | 10.90 | |
| Mar2022 | ₹674 Cr | 10.68 | |
| Mar2021 | ₹609 Cr | - | |
Compare Total Debt of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,632.5 Cr | -6.9% | 9.7% | -33.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -6.9% |
9.7% |
-33.6% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses